A Study of trastuzumab deruxtecan for patients with advanced HER2-positive gastric or gastroesophageal junction adenocarcinoma who have received a prIor Trastuzumab-based regimen accompanied by a disease registry of patients treated with conventional therapies (PROSPERITY)
Sprache der Kurzfassung:
Deutsch
Englische Bezeichnung:
A Study of trastuzumab deruxtecan for patients with advanced HER2-positive gastric or gastroesophageal junction adenocarcinoma who have received a prIor Trastuzumab-based regimen accompanied by a disease registry of patients treated with conventional therapies (PROSPERITY)
Forschungs-